학술논문
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations
Document Type
Article
Author
Source
In: Blood Advances . (Blood Advances, 24 April 2018, 2(8):825-831)
Subject
Language
English
ISSN
24739537
24739529
24739529